VEGDURIS
Live / Applied — Non-final action mailed (as of 31 Jan 2026)
What this means for you
Not registered yet, but its 20 Jan 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97229961
- Mark type
- Stylized text
- Filed
- 20 Jan 2022
- Published for opposition
- 02 Aug 2022
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines
Owner
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prosecution history
- 31 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Jan 2026 — NON-FINAL ACTION E-MAILED
- 31 Jan 2026 — NON-FINAL ACTION WRITTEN
- 31 Jan 2026 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 07 Nov 2025 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 06 Nov 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 13 Aug 2025 — NOTICE OF ALLOWANCE CANCELLED
- 13 Aug 2025 — TEAS DELETE 1(B) BASIS RECEIVED
- 18 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Apr 2025 — SOU EXTENSION 5 GRANTED
- 16 Jan 2025 — SOU EXTENSION 5 FILED
- 17 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Sept 2024 — SOU EXTENSION 4 GRANTED